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The role of granulocytes in the induction of albuminuria in the heterol-
ogous phase of anti-GBM nephritis in the mouse. G Schrijver, KJM
Assmann, MJJT Bogman, RAP Koene, Dept. of Pathology and Dept.
of Medicine, Div. of Nephrology, St. Radboud Hospital, University of
Njmegen, The Netherlands. Anti-GBM nephritis was induced in
Bl0.D2 mice by injection of heterologous antibodies against mouse
GBM. Histologically, the glomeruli showed linear deposits of the
injected antibody along the GBM together with granular deposition of
C3, intravascular influx of polymorphonuclear granulocytes (PMN's),
and deposition of fibrin. In previous experiments we found a
dose—dependent albuminuria that did not disappear in complement
depleted animals. We have now studied the role of PMN's in the
induction of albuminuria. To this end, PMN-depletion (less than 100 per
d) was induced by total body irradiation with 7.5 Gy at four days before
the administration of anti-GBM serum to B10-D2 new mice or congenic
CS deficient B l0.D2 old mice (Table).
Mouse strain
Dose of
antibody mg
Albuminuna at day I (sg/l8 h 5D)
PMN-depletion Controls
B10.D2 new
BlO.D2 old
1.9
7.5
1.9
7.5
45 24 (18)
176 154 (18)
82 48 (6)
616 293 (6)
1248 453 (19)
10,485 5460 (27)
539 250 (8)
4127 1909 (18)
Number of animals in parenthesis
In both models, PMN depletion prevented the albuminuria at low doses
of antibody and depressed it considerably at high doses. Changes in
renal function as measured by serum creatinine were not responsible for
the decreases in albuminuria. Deposition of C3 in the glomerular
capillary wall was similar to that in control animals, while the deposi-
tion of fibnn was completely prevented. The influx of PMN's in the
glomeruli was severely depressed. We conclude that the induction of
albuminuria in this model is largely, if not completely dependent on the
influx of PMN's in the glomeruli.
The effect of polyethyleneimine (PEI) on glomerular antibody (ab)
binding in passive heymann nephritis. PCW Hogendoorn, E De Heer, JJ
Weening, MR Daha, PhJ Hoedemaeker and GJ Fleuren, Departments
of Pathology and Nephrology, University of Leiden, The Netherlands.
The interaction between nephritogenic ab and antigens in the glomeru-
lar capillary wall (gcw) is influenced by electrical charge. PEI is a
cationic polymer which interacts with negatively charged constituents
of the gcw. It has been shown to affect glomerular deposition of
preformed immune aggregates and different charged ferritines in asso-
ciation with a significant decrease in GFR and RPF. We have studied
the effect of neutralization of gcw negative charge by PEI on the binding
of rabbit aFxlA-IgG in the absence of hemodynamic changes. There-
fore, glomerular binding of i.v. administered 0.025 mg radiolabeled (*)
rabbit aFxlA-IgG was determined in Wistar rats preinjected 30 minutes
earlier with 0.2 ml 0.05% PEI (mol wt 40,000) (N = 4) or with 0.2 ml
saline (N = 3). Control rats received 0.025 mg radiolabeled nonimmune
rabbit IgG (NRIgG*) after PEI (N = 3) or saline (N = 3). In a separate
group of animals the effect of PEI was studied on systemic blood
pressure (BP) and on GFR and RPF as measured by inulin clearance
and extraction during ab administration. Glomerular bound ab was
measured in isolated glomeruli one hour after injection and expressed as
promillage of injected counts. aFxlAIgG* binding was found to be
significantly increased in animals pretreated with PEI as compared to
saline (4.64 0.73 vs. 2.80 0.61; P < 0.02). No differences were
found for NRIgG* with or without PEI (1.69 0.01 vs. 1.64 0.84).
The presence of PEI particles in the gcw was confirmed with EM. PEI
was found to have no effect on BP, GFR and RPF during ab adminis-
tration which excludes hemodynamic changes as a cause for the
observed differences in ab binding. It is concluded that binding of PEL
to fixed negative constituents of the gcw enhances the fixation of aFxlA
ab*. This could be due to neutralization of charge of the glomerular
polyanion or to changes in the porosity of the gcw or to a combination
of these phenomena resulting in an increased accessibility for sFxlA*
ab to fix to intrinsic antigens in the gcw.
Glomerular sclerosis in nephrotic rats. Interstrain differences in re-
sponse to puromycin aminonucleoside (PAN). J Grond, H Van Goor, JJ
Weening, and JD Elema, Departments of Pathology, Universities of
Groningen and Leiden, The Netherlands. Administration of PAN to
rats evokes the nephrotic syndrome with proteinuria, hyperlipidemia,
an increased mesangial entrapment of macromolecules, and eventually
focal and segmental glomerular hyalinosis and sclerosis (FSGHS). In
the present study we have explored the effect of PAN in PVG/c rats, a
strain remarkably resistant to the development of proteinuria and
FSGHS after unilateral nephrectomy. Eight male Wistar and eight
PVC/c rats were injected with PAN subcutaneously. The Wistar group
received 20 mg/kg weekly during the first three weeks and subsequently
10 mg/kg every other week during five months. The dose of PAN in
PVG/c rats was monitored on the level of protein excretion in Wistar
rats in such a way that the mean proteinuria during the whole experi-
mental period was similar in both groups. Two rats of both groups died
and were excluded. Mean proteinuria during the five month period in
Wistar rats was 145 12 mg, in PVG/c rats 131 11 mg/24 hr (mean
1 SD, NS). In the Wistar group a total PAN dose of 150 mg/kg was used,
in PVG/c rats 200 mg/kg was required. Morphologic study revealed
FSGHS in 7.9 2.2% of the glomeruli in Wistar rats and in 3.2 2.1%
of the PVG/c glomeruli (P < 0.01). Thus, PVG/c rats are less sensitive
to the proteinuric effect of PAN and are more resistant to the develop-
ment of FSGHS than nephrotic Wistar rats. Since one of the mecha-
nisms involved in the pathogenesis of FSGHS may be mesangial
'overloading' with circulating macromolecular material we subse-
quently studied the mesangial uptake and processing of colloidal carbon
in nephrotic PVG/c rats but found it to be unchanged whereas nephrotic
(FSGHS-prone) Wistar rats show a clearly increased macromolecular
accumulation in the mesangial area during PAN nephrosis. The normal
mesangial function in nephrotic PVG/c rats may be one of the factors
which protects their glomeruli against the development of FSGHS and
indicate that PAN affects the filtration barrier of the glomerular capil-
lary wall and the mesangium via different mechanisms. PVG/c and
Wistar rats may differ in the way the renin angiotensin system reacts to
stimuli such as PAN injection or unilateral nephrectomy.
Effect of protein restriction and converting enzyme inhibition (CEI) on
adriamycin (ADR) nephrosis. JJB Beukers, Ph.! Hoedemaeker, JJ
Weening, State University of Leiden, The Netherlands. ADR induces
glomerular damage with persistent proteinuria after a single intravenous
injection (i.v.). We studied the effect of two isocaloric diets with
different protein content and the effect of captopnl (CAP) on urinary
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protein excretion (UP) and glomerular pathology (GP) in ADR-treated
rats Six groups of female Wistar rats at three months of age were given
3 mg/kg ADR i.v. on day one. Groups 1 and 2 were fed a low protein
diet (6% protein), starting at day two. Groups 3 and 4 were fed a diet
with a 22% protein content, starting at day two. At day 38 the diets of
groups 2 and 4 were reversed to a 22% protein diet and a 6% diet,
respectively. Groups 5 and 6 were fed a 22% protein diet and CAP was
added to the drinking water (500 mg/liter), starting at day two. CAP was
omitted in Group 6 from day 38 on. UP was determined at weekly
intervals with the biuret method. At the end of the 10 weeks observation
period GP, characterized as epithelial cell proliferation, adhesions to
Bowman's capsule and capillary collapse, was studied and quantified by
light microscopy.
GroupN = 4—6
UP, mg/24 hr
day 0 day 36 day 43
l 12 4 195 89 213 100C2 13 4 210 32' 420 167
3f,g 13 7 442 121 484 169
11 6 544 200 256 97
5S 12 6 508 138 731 2016 11 4 595 238 742 257
GroupN = 4—6
UP, mg/24 hr
% GPday 57 day 71l 181 68,d 178 44c,d 6 3cl
2 627 227b 665 142b 30 11"
31,g 589 243C 633 2l4a 26 l4
41 179±107 182±91 7±6
5g 758 234 793 200 31 17
fiS 662 144 757 33 30 11
Values: mean SD; statistics: analysis of variance, a P < 0.05 1 vs.4.bp<0052vs4;cp<OoS I vs. 3;dp<005 vs.2;aP<0.05
3 vs. 4; Groups 1,2,3,4; g Groups 3,5,6.
The results (see Table) show that protein modulation affected UP and
the development of glomerular lesions considerably. In contrast, CAP
had no overt effect. These results suggest that in contrast to the
protective effect of both low protein diet and CEI in the remnant kidney
model, in ADR nephrosis protein restriction and CEI act differently.
Reduction of proteinuria with ACE-inhibition. A comparison with
conventional antihypertensive drugs. JE Heeg, PE de Jong, GK van der
Hem, D de Zeeuw, State University Hospital, Groningen, The Nether-
lands. The effect of the angiotensin-Il converting enzyme (ACE)
inhibitor lisinopril on blood pressure, proteinuria and renal function was
studied in 13 patients with renal disease of different origin. A compar-
ison was made with the effects of conventional antihypertensive drugs
and with a control period without antihypertensive treatment. Both
drug regimens lowered blood pressure significantly: mean arterial
pressure (MAP) was 117 13 mm Hg during conventional therapy
compared to 132 17 mm Hg in the control period (P < 0.01). After 12
weeks of treatment with lisinopril, MPA was 106 15 mm Hg (P <
0.01). Compared to control, lisinopril lowered proteinuria significantly
by 61 40% (P < 0.01), whereas conventional therapy had no
significant effect on protein excretion (—19 40%, NS). Already during
the first eight weeks of treatment with lisinopril, protein excretion was
less compared to conventional therapy (P < 0.05), while there was a
comparable degree of blood pressure reduction. The mean reduction of
proteinuria during lisinopril was associated with a 21 10% (P < 0.01)
fall in glomerular filtration rate (GFR, measured by constant infusion of
1251-iothalamate). However, no con-elation existed between the individ-
ual fall in proteinuria and the fall in GFR. Effective renal plasma flow
(measured by constant infusion of '311-hippuran) did not change;
consequently filtration fraction (FF) decreased by 17 10% (P < 0.01).
The individual fall in proteinuria did correlate positively with both the
change in overall renal vascular resistance (r = 0.66, P < 0.05) and the
change in FF (r = 0.67, P <0.05). This suggests that the antiproteinuric
effect of lisinopril is due to an efferent, postglomerular vasodilatation.
We conclude that the ACE inhibitor lisinopril effectively reduces blood
pressure and proteinuria in renal disease. The latter effect is not a result
of the lower blood pressure per se, but is probably due to a fall in
intraglomerular capillary pressure.
Conversion from cyclosporin to azathioprine three months after renal
transplantation. AJ Hoitsma, JFM Wetzel, HJJ van Lier, JHMBerden,
RAP Koene, Department of Medicine, Division of Nephrology, St.
Radboud Hospital, University of Nijmegen, The Netherlands. In a
prospective randomized trial, 72 recipients of cadaveric renal allografts
received cyclosporin (C5A) for three months followed by conversion to
azathioprine (Aza) and prednisone, and 71 received Aza and prednisone
from the day of transplantation. Although one year graft survival was
better in the CsA treated patients, the difference was not significant
(80% vs. 73%). In the first three months the percentage of acute
rejections was significantly lower in the CsA group (35% vs. 77%), as
was the number of grafts lost due to rejection (1 vs. 10). At three months
after transplantation renal function was significantly worse in the CsA
treated patients. Furthermore, at one and two months the mean MAP
was significantly higher in CsA treated patients than in the control
group (110 vs. 103 mm Hg at two months). This was also reflected in a
higher mean number of antihypertensive drugs necessary in the CsA
group during this period. After conversion an improvement of renal
function was observed. The mean serum creatinine of all CsA-treated
patients decreased significantly (from 155 tmo1/liter to 131 imol/1iter)
at three weeks after conversion (P < 0.001). In the same period no
change in serum creatinine could be detected in the Aza treated
patients. After cessation of CsA the differences between both groups
with regard to MAP and number of antihypertensive drugs disappeared,
Only five patients developed an acute rejection after conversion which
was easily reversible in all cases and did not lead to graft loss. The
numbers of grafts lost after conversion were similar in the CsA and Aza
treated groups. We conclude that the use of CsA for three months with
subsequent conversion to Aza at three months after renal transplanta-
tion reduces the number of acute rejections significantly and appears to
be a safe procedure obviating the long—term side effects of CsA.
X-lmked Alport Syndrome: Localization of the gene in three families. H
Brunner, C van Bennekom,C Schroder, D Menzel, J Tuerlings, £
Lambermon, HH Ropers, L Monnens, Department of Human Genetics
and Pediatrics, University Hospital, Nymegen, The Netherlands, De-
partment of Pediatrics, University Hospital, Essen, Germany. Alport
syndrome is an etiologically heterogeneous disease showing different
patterns of heredity. Both X-linked dominant, autosomal dominant and
autosomal recessive forms of Alport syndrome exist. A linkage analysis
was performed in three families with X-linked Alport syndrome (XAS)
using various DNA-probes. Our results indicate close linkage between
the XAS gene and a DNA marker DXS 17 defined by probe S9. The
recombination fraction between XAS and DXS 17 was estimated at
0.039. This places the XAS gene near band Xq22 in the middle of the
long arm of the X-chromosome. These results suggest that the S9 probe
may be of value for carrier detection and prenatal diagnosis of Alport
syndrome. Furthermore, these observations will facilitate the search for
other closely linked diagnostic markers of the XAS gene in order to
improve the diagnostic accuracy of this method.
The dose—response effect of intravenous dopamine on renal function in
normal man and in patients with renal disease. AJ Smit, S Meder, H
Wesseling, WD Reitsma, AJM Donker, Departments of Medicine and
Clinical Pharmacology, State University Hospital Groningen,
Groningen, and Department of Medicine, Free University, Amsterdam,
The Netherlands. Infusion of a fixed dose of dopamine (1.5 to 2.0
pg/kg/min) has been found to result in an increase in ERPF and GFR in
normal individuals. This increase is less outspoken or absent in patients
with renal disease, even when renal function is within the normal range.
This observation now has been extended by performing renal function
studies during intravenous infusion of dopamine in doses ranging from
'/4 to 8 jzg/kg/min in normal volunteers (N = 15, ages 22 to 57 years) and
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in patients with renal disease and mild to moderate renal function
impairment (N = 21, ages 21 to 61 years, baseline GFR 36 to 96 mI/mm).
Baseline
mi/mm
Dopamine sgIkg/min
1/4 1/2 2 4
Percentage of baseline values
8
GFR
Normals 125.2 13.6
Patients 65 20
103.8NS 108.2 107.1 110.4
— 105.8 106.6 109.4
115.7
—
ERPF
Normals 518.1 101.6
Patients 276 88
111 115.1 136.2 143.8
— 104 118.8 127.1
143.2
—
FF
Normals 0.247 0.034
Patients 0.239 0.031
92.7NS 93.9 78.9 77.7
— 97.1 89.5 86.6
81.4
—
Both in normal persons and in patients all values during dopamine
infusion are significantly different from baseline values unless otherwise
indicated in the table (NS = not significant). Compared to normals,
patients showed a significantly smaller response of ERPF and FF to
infusion of dopamine in doses of sg/kgImin and higher, and 2
sg/kg/min and higher, respectively. No such difference was found for
the GFR. In the patients with renal disease a weak correlation was
found between baseline ERPF and the maximal increase in ERPF
during dopamine infusion (r = 0.482, P < 0.05). This study shows that
intravenous dopamine results in an increase in ERPF and a fall in FF in
a dose—dependent manner, while GFR is much less affected. This
suggests that dopamine induces a predominantly efferent vasodilata-
tion, perhaps due to a preferential location of dopamine receptors in the
efferent arterioles of the glomerulus. In patients with renal disease and
impaired renal function the renal vasodilatory response to dopamine is
impaired.
Long term experience with routine single needle (SN) dialysis: A
review. R Vanholder, S Ringoir, Department of Nephrology, University
Hospital, De Pintelaan 185, 9000 Ghent, Belgium. From 1973, all our
patients were routinely treated with pressure—pressure monitored SN
dialysis. Overall 118,005 dialyses have been performed. Sixty—eight
patients remained on SN dialysis for more than five years, eight patients
were treated for 10 years or more. The experience is in contradiction
with the generally held belief that SN dialysis is inadequate and incited
us to study dialysis adequacy in our unit. Urea kinetics data in our
entire population resulted in a TACr of 0.53 0.06 g/liter for a mean
dialyzer surface of 1. 17 m2 and a dialysis time of 3 x 230 minutes per
week. KTN averaged 0.98 0.10. The corresponding protein catabolic
rate (PCR) was 1.07 0.10 g/kg body wt. These figures correspond to
the NCDS criteria of adequate dialysis. Comparable results were
obtained by direct dialysis quantification (DDQ). The rehabilitation
score was high in spite of a mean age of 51 14 years. The actuarial
survival rate (1975—1985) was calculated to be 90%, 63% and 42% after
1, 5 and 10 years of follow—up. The hospitalization rate over one year
for patients below 60 years of age without cardiac or chronic pulmonary
disorders was 18%. Cumulative five years fistula survival was 74%, a
value corresponding favourably with two needle data. This large,
multifactorial study reveals good dialysis performance and fistula
survival data in long term SN dialysis treatment even when applied in
all patients of a unit without any exception.
Deterioration of renal function of rats with single damaged kidneys on
low or high protein diets. MH De Keijzer, AP Provoost, JC Molenaar,
Dept. of Pediatric Surgery, Erasmus University, Rotterdam, The Neth-
erlands. Once damaged, a kidney may eventually fail to function. The
pathogenic mechanism of the initial damage as well as the dietary
protein intake may be important factors in the rate of functional
deterioration. We investigated the long—term changes in the GFR of rats
with single kidneys, initially damaged by either one week of ureteral
obstruction (UO) or 90 minutes of renal ischemia (RI). Unilaterally
nephrectomized rats (NX) with intact single kidneys served as controls.
Male Wistar rats were operated at an age of four weeks. After operation
the rats were put on a 12% protein diet (LP) or a 36% protein diet (HP).
The GFR was measured every 12 weeks as the plasma clearance of
51-Cr EDTA. The GFR (mI/mm) data are presented in the table.
Week NK (18)
Low protein
RI (18) UO (17) NX (19)
High protein
RI (13) UO (21)
12
24
36
48
60
72
84
96
108
1.29
1.52
1.50
1.43
1.48
1.43
1.23 (15)
0.99(11)
0.81 (7)
1.05
1.25
1.08
0.87
0.73 (15)
0.53 (14)
0.37 (10)
0.16(5)
0.06 (2)
1.16
1.24
0.96
0.66
0.47 (13)
0.29(11)
0.14 (5)
—
—
1.71
1.70
1.67
1.42
1.07 (18)
0.66 (16)
0.38 (13)
0.10(5)
0.02 (1)
1.29
1.08
0.67
0.43 (11)
0.18 (6)
0.05 (2)
—
—
—
1.25
1.01
0.55
0.12 (7)
0.05 (2)
0.01 (1)
—
—
—
(N) is the number of surviving rats
These data show that the GFR of damaged kidneys recovers to about
80% of that of single intact kidneys. Despite this good initial recovery,
the GFR deteriorates to terminal renal failure. The GFR of rat kidneys
damaged by UO decreases more rapidly than those damaged by RI. A
LP diet does not prevent this fall in GFR, but the onset is delayed and
the rate of decrease is less when rats on a LP diet are compared with
rats on a HP diet.
Decrease of glomerular ATP-ase activity induced by adriamycin in the
rat kidney is mediated by oxygen—free radical species. WW Bakker, JFW
BaIler, MJ Hardonk, Department of Pathology, University of
Groningen, Groningen, The Netherlands. It has been shown that both
adnamycin (ADR) as well as the aminonucleoside of puromycin (PAN)
are highly nephrotoxic drugs for rats which readily induce nephrosis
after injection in vivo. As soon as 24 hours following i.v. injection of
ADR, decreased glomerular ATP-ase activity can be demonstrated
cytochemically in the GBM using the cerium—based method at the
ultrastructural level. Intravenous administration of PAN, however, is
not able to change glomerular ATP-ase activity. Since local X-irradi-
ation (2000 rad) upon the kidneys of rats showed identical decrease of
ATP-ase in the GBM, the question emerged whether the early toxic
effect of ADR is mediated by oxygenfree radicals in situ, induced by
ADR in kidney tissue. Therefore, the effect of ADR upon glomerular
ATP-ase activity in vitro was studied by incubation of cryostat kidney
sections (in triplo) from normal rats incubated with 50 j.d containing
0.01, 0.1, 0.5 mg/mI ADR in saline for 16 hours room temperature in
oxygenated atmosphere. A similar series of sections was incubated with
50 1d PAN (0.05, 0.1, 0.5 mg/mI saline). The sections were subsequently
rinsed with buffered saline, pH 7.4, and stained for ATP-ase according
to standard enzymehistochemical methods at the light microscopical
level. Also sections incubated with ADR (0.5 mg/mI) in the presence of
superoxide dismutase (SOD) (3.0, 30 and 300 U/mI) and sections
incubated with SOD (30 and 100 U/mI) alone, were studied. In addition
sections immersed in saline were irradiated (2000 rad), whereas the
saline used was supplemented with or without 30 U/mI SOD. Following
irradiation these sections were also stained for ATP-ase activity. For
comparison finally a series of sections was incubated with Xanthine and
Xanthine oxidase (10 to 20 mm room temperature)—a system well
known for its superoxide—generating capacity—(0.66 mg and 1.65
g-ml; 1.33 mg and 3.30 jsg/ml; or 2.66 mg and 6.6 jsg/ml, respectively)
and studied for glomerular ATP-ase activity. The results show de-
creased reaction product in glomeruli of sections incubated with ADR
solution for 10 minutes in a dose dependent manner, whereas none of
the sections incubated with PAN showed altered glomerular ATP-ase
activity. Interestingly, this effect could be mimicked (again in a dose
dependent manner) by the Xanthine/Xanthine oxidase system suggest-
ing that superoxide radicals are involved in the inactivation of glomer-
ular ATP-ase in vitro. Also in vitro irradiation induced clearly de-
creased glomerular ATP-ase activity. In both ADR-treated sections and
irradiated sections, SOD (30 U/mI) was able to protect the impairment
of glomerularr ATP-ase activity as reflected by the presence of reaction
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product. No alteration in glomerular ATP-ase activity was seen in
sections incubated with SOD alone. It is concluded that superoxide
and/or 0H radical type formation by ADR may be involved in the early
nephrotoxic effect of ADR as reflected in decreased glomerular ATP-
ase activity.
Should booster vaccination with influenza vaccine be recommended in
dialysis patients? DJ Versluis, WEP Beyer, N Masurel, P Kramer,
PhPNM Diderich, W Weimar, Departments of Internal Medicine land
Virology, University Hospital Rotterdam—Dijkzigt, St. Clara Hospital,
St. Franciscus Hospital, Rotterdam, The Netherlands. Annual influ-
enza vaccination has been recommended for patients with chronic renal
failure. However, an impaired antibody response after a single influenza
vaccination was reported in patients on hemodialysis (HD). Although
this group of patients also responds poorly to a single gift of hepatitis B
vaccine, an increase in protection rate for hepatitis B was achieved after
booster immunization. We studied the value of booster immunization
with influenza vaccine (AlPhilippines/2/82 (H3N2), A/Chile/l/83 (H1NI)
and B/USSR/l00/83 (B). Immunization was performed twice on day 0
and 30 by intramuscular route in 98 patients on HD. None received
corticosteroids or immunosuppressive drugs. As controls served 29
healthy volunteers. Protective antibody levels (hemagglutination inhi-
bition test) were regarded to be l00 for influenza A and for
influenza B, Stratification for age, sex, original disease or time on HD
showed no statistical difference in antibody response. After first/second
vaccination the seroconversion rate of previously non protective to
protective titers were H3N2 66/76%, for H1N1 25/31% and for B 27/38%(H1N1 and B, P > 0.001 vs. controls). The increase in overall
protection rate after booster immunization was for H3N2 7%, for H1N1
5% and for B 9%. Our results show that booster immunization with
influenza vaccine does not generate a substantial increase in protection
rate and, therefore, cannot be recommended in patients on HD.
Failure to induce IgA nephropathy by oral or intra-intestinal adminis-
tration of antigen. J Biewenga, GT Noordhoek, AJM Donker, JR
Beukhof, Dept. of Histology, Medical Faculty, Free University, and
Depts. of Nephrology, Academic Hospital, Free University, and
Andreas Hospital, Amsterdam, The Netherlands. On the basis of
clinical and laboratory findings IgA nephropathy is considered to be
connected to a mucosal IgA immune response and IgA immune
complex formation. The search for experimental IgA nephropathy
models has focussed on this conception. One of these models is based
on long—term oral administration of protein antigens to mice. This
model was evaluated using three different strains of mice and trinitro-
phenyl—conjugated ovalbumin (TNP-OVA) as an antigen. IgA immune
complex depositions were not detected in the kidneys of 21 mice treated
with TNP-OVA for 14 weeks, showing that long—term oral administra-
tion of protein antigen cannot be considered a standard model for the
induction of IgA nephropathy. None of 14 animals even developed a
serum anti-TNP response, although an anti-TNP forming cell was
sporadically found in the tissues. After repeated intra-intestinal antigen
administration, IgA-anti-TNP antibodies were found in the serum in
addition to IgG-anti-TNP antibodies in two of 21 animals but IgA
immune complex deposits did not occur in the animal's kidneys. An
intravenous boost injection after intra-intestinal priming evoked a
higher IgA antibody response; however, it did not induce the deposition
of IgA immune complexes in the mouse kidney. The results were the
same in all three mouse strains. Considering that IgG antibodies might
compete with IgA antibodies in forming immune complexes, mice were
injected with murine plasmacytoma MOPC-315 cells, thus introducing
circulating IgA anti-TNP cross—reacting antibodies without IgG-anti-
TNP antibodies. When antigen was given to animals with different
levels of circulating antibody, IgA immune complexes deposited in the
kidneys at the higher antibody levels. In contrast to IgA nephropathy in
man, hematuria was not detected in animals having mesangial IgA
deposits which is in accordance with previous studies. Therefore, the
experimental IgA nephropathy models described so far, differ from the
human disease.
Measurement of transcellular fluid shifts during hemodialysis. PMJM
de Vries, JH Mejer, PL Qe, H van Bronsyk, H Schneider, AJM
Donker, Departments of Internal Medicine and Medical Physics,
Academic Hospital of the Free University, Amsterdam, The Nether-
lands. Patients undergoing maintenance hemodialysis frequently suffer
from headache, nausea, vomiting, fatigue and hypotension during or
after dialysis. A fall in the extracellular osmolality causing a transcel-
lular fluid shift into the cell is thought to cause these symptoms. In order
to study this fluid shift, a tetrapolar electrical impedance technique was
developed in our departments which measures the electrical impedance
of the forearm from three to 200 kHz. Using a computer model, the
intra- and extracellular admittances can be calculated separately. These
admittances represent the fluid volumes of both compartments. Six
stable patients on maintenance hemodialysis were studied during three
dialysis strategies: (A) five hours routine dialysis; (B) one hour ultrafil-
tration followed by five hours dialysis; (C) five hours dialysis preceding
one hour ultrafiltration. Impedance measurements were performed
hourly. During all 18 sessions a relative transcellular fluid shift was
measured: the extracellular fluid volume (EFV) decreased significantly
more than the intracellular (IFV). The rate of fluid shift was most
pronounced during the first hour and decreased towards the end of
treatment. Ultrafiltration caused an even stronger increase of the ratio
IFV/EFV. At the end of dialysis the total increase was similar during
strategy B and C, but significantly less during strategy A. The amount
of disturbance of the equilibrium between both compartments corre-
lated well with the amount of fluid removal. The reproducability of our
method was good. Duplo measurements correlated well (r = 0.9975). A
positive correlation also existed between the decrease of admittance
and the weight decrease during dialysis (r = 0.65). It is concluded that
the electrical impedance technique is a useful tool to measure IFV and
EFV separately. The results indicate that during hemodialysis a
transcellular fluid shift occurs, that is strongest during the first hour and
during ultrafiltration. The relation between fluid shifts and dialysis
morbidity and the influence of interventions will be studied.
Prevention of renal function decrease with verapamil (V) and cimeti-
dine (C) in patients treated with cisplatin (CP). JJG Offerman, GK van
der Hem, DTh Slejjfer, S Meyer, Department of Internal Medicine,
University Hospital, Groningen, The Netherlands. Thirteen patients
(group A) with histologically—proven disseminated testicular cancer
were treated with combination chemotherapy containing CP according
to the Einhorn regimen. Renal function studies were performed before
chemotherapy was given (= day 1), on day 10 and finally, before the
second course (= day 21). The renal function studies consisted of the
measurement of the effective renal plasma flow (ERPF) and the
glomerular filtration rate (GFR) using '311-hippurate and '251-sodium
thalamate, respectively. To prevent CP-induced renal toxicity, V and C
were administered orally, starting one day before the start of the CP
treatment, in a daily dose of 80mg t.i.d. and 200 mg t.i.d., respectively.
Extra 400 mg C was given i.v. on days one to five before every CP
infusion. The results were compared with a historical control group of
nine patients (group B) treated with CP alone, On day 10 the median
ERPF decreased in both groups: group A —7.6%, group B —16.5%
(NS). On day 21 the median ERPF decrease in group A was —4.5%
versus a decrease of —29.0% in group B (P < 0.01). The median GFR
on day 10 decreased in group A only —0.7%. In group B a decrease of
14.1% was found (P < 0.05), and on day 21 the GFR in group A
increased with +4.9% versus a decrease of —29.4% in group B (P <
0.001). In group A we also determined the DMSA-ratio (a marker for
proximal tubular function) on days 10 and 21. All values found were in
the normal range (P < 0.14). In conclusion, the combination of
verapamil and cimetidine given to cisplatin—treated patients was able to
significantly reduce the ERPF decrease on day 21. Further, it was also
able to prevent the GFR decrease on days 10 and 21 normally found in
patients treated with cisplatin.
The influence of peritoneal dialysis fluid on the local host defenses of
CAPD treated patients. H van BronswUk, HA Verbrugh, J van der
Meulen, PL Oe, J Verhoef, Free University Hospital, Amsterdam and
State University of Utrecht, The Netherlands. Since the first clinical
experience with peritoneal dialysis the high frequency of peritonitis has
been considered the major limitation of this technique. Very limited
knowledge existed on local host defenses in the abdominal cavity of
patients treated by continuous ambulatory peritoneal dialysis (CAPD).
We studied the influence of fresh CAPD fluids and dialysates that have
remained in the peritoneal cavity for four to six hours on human
phagocytic function. In addition, fluids modified regarding their acidity
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and osmolality (glucose content) were investigated. The ability of
human polymorphonuclear leukocytes (PMN), monocytes (MN) and
peritoneal macrophages (PMØ) to mount a respiratory burst was tested
in a phorbolmyristate acetate—stimulated chemiluminescence (CL) as-
say. Fresh CAPD fluids severely depressed the CL response of all three
phagocytes tested. The suppression was irreversible after incubation
during 60 minutes or longer in dialysate containing 4.25% glucose.
When tested in effluent dialysis fluids, PMN, MN and PMØ CL was 30
to 32% of their respective CL in control buffer. Similar levels of CL
were recorded in CAPD fluids that had been neutralized to pH 7.35.
Phagocytosis of E. coli by PMN and MN in fresh CAPD fluids was
suppressed to 35 and 62%, respectively. Bactericidal capacity of PMN
and MN was not detectable in fresh CAPD fluids. A decreased
production of oxygen radicals was demonstrated by PMN oxygen
consumption measurements. Both the low pH value and the high
osmolality of commercially available CAPD fluid seem to be responsi-
ble for the detrimental effect on phagocytic function. Our investigations
add support to the peritoneal cavity of CAPD patients being a severely
immunocompromised environment. Further efforts to prevent peritoni-
tis in CAPD treated patients should include modifications of the
peritoneal dialysis fluid, making these less toxic to the peritoneal
defenses.
Donor age: A risk factor for kidney transplantation. KML Leunissen,
M Ramentol, G Kootstra, F Bosman, JP van Hooff, University Hospi-
tal, Maastricht, The Netherlands. Recently a considerable increase of
the % of patients, who needed dialysis after transplantation (ATN) was
observed in our center. Two changes of the protocol might be respon-
sible for this increase: the introduction of cyclosporin A (CyA) and an
increase of the upper age limit for cadaveric kidney donors. Therefore,
a retrospective study was performed to the relationship between CyA,
donor age, ischemic lesions in the donor kidney and renal allograft
outcome. Three groups of patients with a functioning cadavenc kidney
graft after three months have been studied: 1.) CyA + donor age  40
years (N = 29); 2.) CyA + donor age > 40 years (N 24); 3.)
azathioprine (Aza) ÷ prednisolone. (N = 29). During transplantation all
patients were hydrated according to the same protocol. Biopsies of the
donor kidneys were taken one hour after reperfusion. The presence
and/or absence of ischemic lesions were scored. CyA was given i.v. 4
mg/kg/day in the first 48 hours, thereafter orally 8 mg/kg/day. The
dosage was adjusted to keep the trough levels between 0.10 to 0.20
mg/liter (whole blood, HPLC). CyA was converted to Aza and Pr when
there was a serum creatinine above 300 j.mol/liter at three months.
Relevant data are given in the Table.
Gr. I
N=29
Gr. II
N=24
Gr. LII
N=29
Mean age
ATN
Abn.histology
ATN/Abn.histology
Creat.cl. 3 months
Conversion
23 11
11(38%)
9 (31%)
7/9
52
4
*
**
**
52 12
18 (75%)
20 (83%)
15/20
30
11
***
**
***
30 14
5 (17%)
8 (27%)
2/8
78
* P < 0.05; ** P < 0.01; P < 0.001
In conclusion, during CyA an increased % of ATN is found compared
to the historical control (respectively 55 and 17) especially when
kidneys are used from donors > 40 years. Ischemic lesions are found
very frequently even in kidneys from young donors. The combination of
either ischemic lesions or an "old kidney" with CyA is leading to a high
chance of ATN, low creatinine clearance at three months and a high
chance on conversion to AZA + Pr.
Pharmacokinetics of azathioprine (AZA) and 6-mercaptopurine (6-MP)
after oral administration of AZA. J Salemans, A Hoitsma, R de Abreu,
D de Vos, Division of Nephrology, University of N,jmegen, The
Netherlands. Although AZA has been used as an immunosuppressive
drug for more than twenty years, little is known about its
pharmacokinetics mainly because of the absence of a reliable assay to
measure AZA and 6-MP levels. The development of an accurate
high—performance liquid chromatography analysis enabled us to study
the pharmacokinetics of AZA and its primary metabolite 6-MP in 12
kidney transplant recipients with stable renal function (mean serum
creatinine 220 mol/liter, range 121 to 393). Blood samples were drawn
at 0.5, 1, 2, 3,4, 5, 6, 8 and 12hours after a single oral dose of AZA (3
mg/kg). The urine of each patient was collected until 12 hours post-
dose. No AZA was detected in plasma at any time. The mean peak
plasma concentration of 6-MP was 144 41 nmol/liter, with a mean
time to peak of 1.8 0.4 hr. The 6-MP levels fitted a simple first order
kinetic process with a mean half life (T½) of 1.9 0.5 hr. There were
wide interpatient differences in 6-MP levels. Twelve hours post-dose
6-MP levels of all patients were below the detection limit (16 nmol/liter).
One patient who was on phenobarbital medication had markedly lower
6-MP levels, probably due to induction of drug metabolizing liver
enzymes. No AZA was detected in the urine. Urinary excretion of
6-MP was less than 1% of the dose of AZA. There was no correlation
between creatinine clearance and either urinary excretion or T'/2 of
6-MP. We conclude: 1) AZA is rapidly converted to 6-MP in vivo; 2)
determination of 6-MP plasma levels in kidney transplant recipients
who receive AZA might be of clinical importance because of marked
differences in 6-MP metabolism and possible drug interactions (a
retrospective analysis of all transplanted patients revealed a signifi-
cantly higher number of rejections in patients using phenobarbital); 3)
reducing the AZA dosage at lower creatinine clearances is disputable
and may lead to undertreatment, because 6-MP is mainly cleared by
non-renal mechanisms; 4) administration of AZA more times daily
seems preferable because of the short half life of 6-MP.
Antibodies directed against laminin and type IV collagen in experimen-
tal trypanosomiasis—related glomerulonephritis. JA Bruijn, BS Oemar,
JHH Ehrich, JM Foidart, GJ Fleuren, Department of Pathology,
Leiden State University, The Netherlands, Department of Pediatrics,
Medical School, Hannover, Federal Republic of Germany and Depart-
ment of Gynecology and Obstetrics, University of Liege, Belgium.
Infection with Trypanosoma brucei (T. brucei) in BD IX rats leads to
development of an immune complex glomerulonephritis and protein-
uria. We studied the development of renal disease in this model and
investigated the nature of the antigens and antibodies involved. For the
experiment, 45 rats were infected with 1000 T. brucei i.p. and 20 rats
were used as a control. The infected animals developed proteinuria up
to 236 35 mg/24 hr after seven weeks. Deposits of immunoglobulins
and complement were found at week three in a linear, and after seven
weeks also in a granular arrangement along the glomerular basement
membrane (GBM). In both the sera and kidney eluates from diseased
rats, antibodies were present that bound in a linear fashion along the
GBM on sections of kidneys from normal animals. ELISA studies
showed antibody activity to be directed against the GBM-components
laminin and type IV collagen. These antibody activities decreased in
time, showing an inverse relationship with the development of both
parasitemia and proteinuria. Antibodies directed against laminin and
type IV collagen are known to be able to induce renal disease, and they
might well be the cause of glomerulonephritis and proteinuria in this
model. Using indirect immunofluorescence, no common antigenic sites
were found on Trypanosomes and GBM-components. The formation of
auto-antibodies directed against laminin and type IV collagen seems to
be caused by polyclonal B-cell stimulation, a well known feature of
Trypanosomiasis.
IgA antibody response to rabbit anti-thymocyte globulin In renal
transplant recipients. PS Hiemstra, WM Baldwin, EAM van der Voort,
MR Daha, LC Paul, LA van Es, Department of Nephrology, University
Hospital, Leiden, The Netherlands. Anti-thymocyte globulin (ATG) is
used in organ transplantation to suppress cellular immunity. Some
investigators have described the production of antibodies against the
heterologous ATG in transplant recipients. To further analyze this
response, we have studied the kinetics, class and quantity of anti-ATG
antibodies in 25 renal transplant recipients who had received rabbit
ATG intravenously for treatment of a rejection episode. In the serum of
all patients antibodies to rabbit IgG were detected. Using an ELISA
system employing monoclonal antibodies specific for human immuno-
globulin classes, it was observed that all patients produced IgO, and the
majority produced IgA and 1gM as well; the antibodies were directed
against the Fc portion. There was no reactivity with rhesus or human
1048 Abstracts
IgG suggesting that the antibodies had no rheumatoid factor activity.
The onset of the antibody response was first detected six to 48 days
after the first injection of ATG. The 1gM and IgA responses decreased
within one to two months, whereas the IgG response remained elevated
for two to 12 months. Size analysis of the antibodies by gelfiltration
indicated that the IgA and 1gM antibodies directed to rabbit IgG were
polymeric. When the anti-ATG containing sera were fractionated by
gelfiltration and the fractions were used to react with rabbit IgG-coated
ELISA plates followed by washing and subsequent interaction with
purified secretory component (s.c.), it was found that the IgA antibod-
ies were fully reactive with s.c., also suggesting the polymeric nature of
the IgA. No correlation was observed between the extent and the class
distribution of the antibody response, and the clinical symptoms and
laboratory findings. Although the patients had received ATG by the
intravenous route, a polymeric IgA response was observed. The
question therefore arises concerning the site of stimulation of the
antibody response. These studies may provide insights into the factors
involved in IgA nephropathy, a disease characterized by polymeric
IgA.
Deleterious effect of the diphosphonate APD on histology of renal
osteodystrophy. RJ Hené, WJ Visser, EJ Dorhout Mees, JA Raymakers,
SA Duursma, J Vos, RJ de Bos Kuil, University Hospital, Utrecht, The
Netherlands. It is known, that APD effectively decreases serum cal-
cium (sCa) in patients with malignancy—associated and post-transplant
hypercalcemia, possibly by an inhibitory effect on the osteoclasts. To
investigate the effect on patients with renal osteodystrophy we gave it
to five hypercalcemic patients with renal insufficiency (3 patients on
hemodialysis received 15 mg APD iv. three times a week, two with
severe renal failure received 200 mg APD daily, orally). Before and
after treatment (which lasted 2 to 17 months) sCa, alkaline phosphatase
(sAlk Phos) and semm PTH were determined and a bonebiopsy taken.
In four of five patients sCa dropped; thereafter they were treated with
vit D. In all cases there was a remarkable increase in bone marrow
fibrosis. In all but one (the patient with the lowest FF11 and best renal
function) there was a striking increase in the amount (V) of osteoid and
number of osteoclasts (oc) and osteoblasts (ob), the amount of bone did
not change.
Pretreatment APD Ref Val
sCa mmol/liter 2.93 0.25 2.80 0.19 2.2—2.6
sAlk Phos U/liter 290 90 375 198 45—120
sPTH pmol/liter 254 199 233 128 1—5
Vbone % 230 60 290 111 159—247
Vostoid % 9.3 3.7 28.8 22.9 1.5—8.7
Vfibrosis % 10 7 129 86 0
ob % 20.2 8.1 31.9 14.0 1.0—9.9
oc % 4.7 3.1 12.0 6.0 0.1—0.9
oc 1mm2 5.8 6.5 15.5 11.4 ?
The most striking effect was the generation of a large number of
polymorphic multinucleated giant cells (oclmm2), embedded in fibrous
tissue, with little or no role in active bone resorption. Conclusion: APD
decreases sCa slightly but causes a deterioration of the histological
appearance of the bone in renal failure.
The influence of indomethacin on the circadian rhythm of proteinuria
in patients with nephrotic syndrome. MG Koopman, RT Krediet, FMJ
Zuyderhoudt, EAM de Moor, L Arisz, Academic Medical Centre,
Amsterdam. In nine patients (pts) with nephrotic syndrome we studied
urinary excretion of albumin, transferrin and IgG every three hours
during three successive days without medication (I—), followed by a
study period of three days with 150 mg indomethacin per day (1+). Pts
were sodium depleted and studied during a regimen of bedrest and
spaced—identically meals. Circadian variability of proteinuria was com-
pared between I— and 1+ for every patient and every protein. The
relative amplitude (A/MxlOO%) and the phase of the circadian rhythm
were calculated by a computer program. Urinary albumin, transferrin
and IgG excretion per 24 hours were lower on (I+)day one and
remained lower on (I+)day three. Albumin decreased to 55% (P <
0.01), transferrin to 57% (P < 0.01) and IgG to 72% (P < 0.05) of the
initial value. GFR and PRA also decreased during 1+ (P < 0.01). Only
on (I+)day one a decrease in urinary potassium and water excretion per
24 hours was observed (P < 0.05, P < 0.01, respectively). During I—,
seven of nine pts had a circadian rhythm for urinary excretion of
albumin, transferrin and IgG with a diurnal maximum and a nocturnal
minimum and a mean A/M of respectively 60%, 60% and 103%. Mean
A/M was higher during 1+ for all three proteins (88%, 96% and 123%;
P < 0.01, P < 0.01 and P < 0.05). The two pts without a proteinuria
rhythm during I— did have a rhythm for all three proteins during 1+.
The phase of the rhythms was similar during I— and 1+. In conclusion,
indomethacin induced a decrease in the urinary excretion of albumin,
transferrin and IgG, but an enhancement of the relative amplitude of
their rhythms.
Effect of cyclosporine on fractional excretion of lithium and potassium
in kidney transplant recipients. HH Vincent, W Weimar, MADH
Schalekamp, Department of Internal Medicine I, University Hospital,
Rotterdam, The Netherlands. Cyclosporine has been demonstrated to
decrease the fractional excretion of lithium and potassium in rats. We
studied these effects in nine patients admitted for cadaveric kidney
transplantation. They were treated with prednisone, 15 mg, and with
azathioprine and antilymphocyte globulin until graft function was
established. Urinary clearance of creatinine (Ccr), lithium (CLI), sodium
(CNa) and potassium (CK) were measured, and cyclosporine (CyA), 14
mg/kg/day in two oral doses, was started. After four days serum CyA
trough level was 180 29 ng/ml, and clearance measurements were
repeated. The normal relationship between CL/CC, and CNa/Ccr was
established in 32 volunteers. Linear regression analysis yielded the
equation CLI/Ccr = 5.6 CNa/Ccr + 0.16 (r = 0.76), which was used to
correct CLI/CCr for sodium excretion in the kidney transplant recipients.
Before CyA After CyA t-test
Ccr mi/mm 73 II 63 6 NS
CNa/CCr% 1.49 0.20 1.61 0.27 NS
CLI/Ccr % 32 3 21 2 P < 0.02
CLI/Cc, obs/pred 1.30 0.16 0.81 0.04 P < 0.01
CK/CCr % 20 5 9 3 P < 0.05
Serum K mmol/liter 4.2 0.2 4.7 0.2 P < 0.05
There was a linear correlation between CL1/CCr and CK/CCr, both before
and after CyA, and between the change in CLI/CCr and the change in
CK/CCr (r = 0.75; P < 0.01). Conclusion: Cya reduces CLI/Ccr, which is
an indication of increased proximal tubular fluid resorption. This effect
may be a more reliable index of CyA toxicity than Ccr. Reduced
delivery of fluid of the distal tubular system is largely responsible for the
impaired potassium excretion.
Loss of edema-preventing force in non-edematous tissue of patients with
nephrotic syndrome (NS). B Braam, HA Koomans, JD Banga, U
Dorhout Mees, University of Utrecht, The Netherlands. Patients with
hypoproteinemia due to the NS are able to maintain their blood volume
probably by mobilizing their edema—preventing forces, such as, by
lowering tissue—fluid protein concentration. If this notion is correct, NS
patients must to some extent have spent their edema—preventing forces
in places were no edema exists. To analyze this, we studied the effect
of increased venous pressure in the upper arm (Periflow, Janssen
Instrum.) on the volume of the (nonedematous) forearm (strain gauge
plethysmography) in eight healthy subjects and five NS patients.
Plasma oncotic pressures were 24.3 2.5 and 14.6 mm Hg,
respectively. Raising venous pressure in 2 mm Hg steps every 15
minutes, we found in the normal subjects a slow initial rise in forearm
volume (0.8 0.6 vol%/hr), which suddenly increased threefold (to 3.1
0.9 vol%/hr) when elevation of venous pressure surpassed 14 to 16
mm Hg. In the NS patients this enhanced increase of the forearm
volume (3.4 1.1 vol%/hr) was already seen when venous pressure was
raised by 6 mm Hg. These data are compatible with the idea that a great
deal of the NS edema—preventing force has indeed been spent in
compartments without visible edema.
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Hypoproteinemia and fluid volumes in dogs. JA Joles, HA Koomans,
W Kortlandt, P Boer, EJ Dorhout Mees, Department of Nephrology,
Utrecht University, The Netherlands. Batch—plasmapheresis (PF) and a
low protein diet were used in nine experiments to obtain hypoprotein-
emia in five otherwise healthy, splenectomized male beagles (16 1
kg). Blood volume (BY; calculated from Evans blue space and hema-
tocrit) and extracellular volume (ECY; estimated from 82-bromide
space) were measured in the control state; 21 hours after PF; 45 to 69
hours after PF and during recovery. In addition in four dogs interstitial
colloid osmotic pressure (COP) in fluid collected from subcutaneous
wicks was measured, allowing calculation of the transcapillary COP-
gradient (LCOP = plasma (p) COP — interstital COP).
Control 21 hr after PF
pCOP (mm Hg; N=9) 21.6 2.6 10.0 14a,b
pProtein (giliter; N=9) 59.1 4.3 32.2 42a,b
pAlbumin (giliter; N=9) 34.4 5.0 12.7 5.6"''
BY (liter; N=7) 1.44 0.07 1.34 0.08"
ECV (liter; N=8) 4.25 0.29 5.01 0.90"
zCOP(mmHg;N=4) 6.1 0.1 5.6 1.2
45 to 69 hr after PF Recovery
pCOP (mm Hg; N=9) 12.2 2.9"' 18.1 2.8
pProtein (giliter; N=9) 433 54a.b.a 57.6 6.5
pAlbumin (giliter; N=9) 14.1 6Øa,b 21.9 7•5a
BY (liter; N=7) 1.46 0.19 1.38 0.17
ECV (liter; N=8) 4.44 0.89" 4.39 0.45
zCOP(mmHg;N=4) 5.6±3.3 4.1± 1.4
Mean SD, P < O.OS:a as compared to control,b as compared to
recovery,c as compared to PF. Assessing sodium excretion post-PF we
observed that retained fluid was excreted at a plasma COP of 9 to 10mm
Hg (plasma protein 26 to 33 glliter) in three dogs in which we were able
to depress plasma protein under this level. We conclude that (1)
although BY is depressed 21 hours after PF, hypoproteinemia as such is
not associated with hypovolemia; (2) fluid retained during PF can be
excreted at a plasma COP of 9 to 10 mm Hg and possibly less; and (3)
the transcapillary gradient is not reduced at the level of hypoprotein-
eniia achieved in this study.
Natriuresis but not rise in glomerular filtration rate (GFR) after atrial
natriuretic peptide (ANP) is blunted in sodium (Na) restricted normal
man. C Gaillard, H Koomans, P Boer, EJ Dorhout Mees, University of
Utrecht, Department of Nephrology, Utrecht, The Netherlands. We
studied the effect of an intravenous bolus of 100 g a-human ANP on
renal Na handling in 10 healthy subjects twice, on a 20 and on a 200
mmol Na diet. Clearance studies using 20 minute urine collections
showed that the rise in GFR (inulin clearance) was similar ("" 12%) on
the two diets, but the rise in Na excretion UNaY, mol/min) much less
during the low Na intake.
Na intake
20 mmol 200 mmol
Baseline ANP Baseline ANP
GFRmI/min
FPRNa%
FDRNa %
FELi %
UNaY
Uosmol
111 7"
91.0 0.5a
96.7
26.8 l.6a
47 II"
61.0 4.0
123 8
88.1 0.7
90.0 1.5
33.0 1.8
177 23
64.5 4.1
116 8"
88.6 0.6a
86.8 1.5"
29.0 l.3a
226 20"
66.8 4.5"
130 8
82.5 0.5
68.3 2.7
38.2 1.7
899 76
94.1 6.7
"P < 0.05
Fractional proximal and distal Na reabsorption (FPRNa and FDRNa),
estimated from maximal free—water clearance, dropped after ANP, the
fall being more pronounced during the 200 mmol Na diet. Fractional
excretions of lithium, phosphate, calcium, uric acid and magnesium
increased more when ANP was given during the 200 mmol Na diet.
Minimal urine osmolality (Uosmol, mOsm/kg) rose after ANP admin-
istration during the 200 mmol Na diet only. These results indicate that
the variability of ANP-induced natriuresis with Na intake is not caused
by different effects on GFR, but by different Na handling at proximal
and distal nephron levels.
Mechanism of the renal natriuretic action of atrial natriuretic peptide
(ANP) in man. WMT Janssen, PE de Jong, GK van der Hem, D de
Zeeuw, Department of Nephrology, State University Hospital,
Groningen, The Netherlands. We studied the effect of 1.0 sg ANP/min
on free water clearance (CH2O) and free water reabsorption (TCH2O)
during a stable phase of water loading (WL) and mannitol (10% in
saline) loading (ML), respectively, in seven normotensive volunteers.
The effects of ANP infusion (120 mm in WL and 80 mm in ML) are
given as the mean (± SD) percent change compared to the pre-infusion
period. After ANP infusion, GFR increased 9.0 2.0% during WL (P
= 0.02) and 6.3 4.9% during ML (P = 0.02), whereas ERPF fell by 9.8
4.7% (P < 0.05) and 6.0 7.6% (NS), respectively. Filtration fraction
(FF) thus increased 16.9 7.8% (P =0.02) and 11.9 9.6% (P = 0.02).
CH2O/GFR increased 10.7 9.1% (P = 0.02) with a rise in FENa of 158
153% (P < 0.05). The rise in FENa was correlated with the rise in
CH2OIGFR (r = +0.88, P < 0.01). TCH2O/GFR, as calculated from the
Cosm/GFRadjusted value, fell 10.3 9.8% (P = 0.02) with a rise in
FENa of 82 56% (P = 0.02). Again, a greater fall in TCH2O/GFR was
observed in subjects with a higher increase in FENa (r = 0.95, P < 0.01).
The observed increase in CH2O/GFR suggests the natriuretic action site
of ANP to be proximal of the thick part of the ascending loop of Henle
(ALH). The fall in TCH2O/GFR suggests a medullary site of action of
ANP, including the thin and thick part of ALH. Solute reabsorption in
the thin medullary part of the ALH is passive and dependent on the
medullary solute gradient. A decrease in passive solute reabsorption in
the thin part of ALH will result in a fall in TCH2O and in a rise in CH2O;
the latter resulting from the increased amount of sodium delivered to
the diluting site. The ANP induced changes in CH2O and TCH2O can thus
be explained by a medullary solute washout. A rise in medullary blood
flow will induce such a dissipation of the medullary solute gradient.
Medullary nephrons have a lower hippuran extraction and a higher FF.
As such, the fall in ERPF and the rise in FF observed after ANP are in
favor of this suggestion. We thus conclude that the natriuretic effect of
ANP can be explained by a change in intrarenal hemodynamics with a
rise in medullary blood flow resulting in an inhibition of solute reab-
sorption in the thin part of ALH.
The dihydropyridine calcium antagonist felodipine antagonizes the
renal effects of exogenous angiotensin II in normotensive volunteers. HE
Sluiter, JFM Wetzels, FThM Huysmans, RAP Koene, Department of
Nephrology, Sint Radboud University Hospital, Nijmegen, The Neth-
erlands. Felodipine has a natriuretic effect in normotensive volunteers.
Low intravenous doses of angiotensin II (All) are antinatriuretic. In
vitro, several effects of All are antagonized when a calcium antagonist
is given. We studied the effects of a graded infusion of All on renal
function during intravenous felodipine (F, 0.009 mg/mm) or placebo (P)
in a double—blind study in 12 healthy volunteers (100 mmol Na/24 hr).
Just before All, blood pressure (MAP, F 75.7 2.1 mm Hg, mean
SEM, P81.5 2.8mm Hg, P <0.05) was lower, and fractional excretion
of Na (FeNa, F 3.0 0.3%, P 0.9 0.1%, P < 0.001) and PRA (F
2.0 0.2, P 1.3 0.1 ng/ml/hr, P < 0.05) were higher on F. GFR
(C1011, F 99 4, P 109 5 mI/mm), ERPF (CPAH, F 617 29, P 615
29 mI/mm), and plasma aldosterone (F 6.0 0.9, P 6.7 0.7 nmol/100
ml) were similar on F and P. F prevented the All-induced falls in
FeNa, ERPF and GFR (Table), and partly antagonized the rises in
MAP and aldosterone. The fall in PRA by All was not affected by F.
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Dose All
ng/kg/min 0.3 1.0 3.0
FeNa % F
P
—0.15 0.13
—0.14 0.05
—0.11 0.19
—0.26 008"
+0.78 0.42"
—0.42 0.09"
GFRmI/mjn F
p
+7±594a +12±6a7±5 +18±8a—7±4
ERPF mi/mm F
P
+6 36
—85 28"
—8 39
—109 27"
—38 53
—175 22b
Means SEM, a P < 0.05, b P < 0.01, compared with baseline.
It is concluded that interference with the renal effects of All may be
involved in the acute natriuretic effects of dihydropyridine calcium
antagonists.
Pulmonary dysfunction is common during a cytomegalovirus (CMV)
infection after renal transplantation even in asymptomatic patients. WJ
van Son, J Duipmans, Th van der Mark, TH The, M Slooff, R Peset, A
Tegzess, Department of Medicine, University Hospital, Groningen,
The Netherlands. CMV infection is frequently seen after cadaveric
renal transplantation (CRT), and its symptomatology may show a great
variety. CMV pneumonitis can also be a potentially dangerous feature
of the CMV syndrome post-transplant and is associated with arterial
undersaturation and chest X-ray abnormalities. Measuring of diffusing
capacity of the lungs for carbon monoxide (KCO) can be a sensitive
marker for functional disturbances of pulmonary gastransport in vari-
ous interstitial pulmonary afflictions even before X-ray abnormalities
are present. We measured KCO with a rebreathing technique in eight
patients with an active CMV infection (defined as a fourfold or greater
rise in antibodies to CMV early and late antigens) without pulmonary
symptoms, arterial bloodgas abnormalities or abnormalities in X-ray.
Four patients had a primary CMV infection and four patients a
reactivation. In a control group of 12 patients after CRT KCO was
measured in a stable phase after CRT or during rejection. There were no
statistical differences in mean age or mean hemoglobin (Hb) concentra-
tion between both groups. KCO was significantly lower (P < 0.005,
Student's t-test) in the CMV group as compared to the control group
(when corrected for Hb concentration P < 0.01). We conclude that
KCO is decreased during an active CMV infection after CRT, even
without pulmonary symptoms or abnormalities in bloodgases or X-ray.
It could have both theoretical and clinical implications for the some-
times difficult diagnosis of CMV infection after CRT and furthermore, it
could be of help in differentiating CMV infection from rejection after
CRT. The decreased KCO may reflect a primary cytopathogenic effect
of the CMV on the lung parenchyma, or it could be a complement
mediated phenomenon, as complement is activated during an active
CMV infection.
Omega-3 polyunsaturated fatty acids improve lipid profile and lower
blood viscosity in CAPD patients. BAC van Acker, HJG Bib, C
Rustemeyer, H van Bronswi)k, TFonk, C Popp—Snyders, C Molder, JA
Schouten, AJM Donker, Free University Hospital, Amsterdam, The
Netherlands. Patients with severe renal failure are known to have an
altered lipid profile with a decrease of HDL-cholesterol and an increase
of triglyceride levels, contributing to an acceleration of atherosclerosis.
High blood pressure is also common in this group. Omega-3 polyunsat-
urated fatty acids (eicosapentaenoic acid, EPA, 20:5 omega-3, and
docosahexaenoic acid, DI-IA, 22:6 omega-3) are known to improve the
lipid profile and lower blood pressure in certain defined patient catego-
ries. Contradictory reports exist regarding the effects on blood viscosity
and platelet count. We therefore evaluated the effects of an eight-week
addition of six grams of "Super-EPA" (= three grams of EPA + DHA,
Pharmacaps, GB) to their normal diet in nine CAPD-patients.
HDL2 - C
mmol/liter
HDL2±3 - C
mmol/liter
Trigl
mmoi/liter
Hb
mmol/iiter
Before 0.37 1.05 2.3 5.7
EPA 0.06 0.3 0.5
After 055b 1.26" 16b 5.8
EPA 0,11 0.2 0.6
MCH
amoliter
MCV
fi
MCHC
mmol/liter
Weight
kg
Before 1870 92 20.4 77.7
EPA 18 1 0.1 4.7
After l800 88 20.5 '79.2"
EPA 29 1 0.3 5.0
(mean SEM, Wicoxon signed-rank test a P < 0.05, "P <0.02)
Blood pressure and platelet count did not change. Lipid profile im-
proved. The plasma phospholipid P/S ratio increased. The viscosity of
erythrocyte suspensions at Ht = 0.80decreased at all shear rates except
the lowest. We, therefore, conclude, that the addition of a small amount
of omega-3 polyunsaturated fatty acids to the normal diet of CAPD
patients results in an improved lipid profile. The lowered viscosity
indicates an increased erythrocyte flexibility. Whether these improve-
ments can result in a deceleration of atherosclerosis and a lower
incidence of cardiovascular complications in CAPD patients is yet
unknown. Further studies are warranted.
Combined kidney and pancreas transplantation: Early experience. JP
van Hooff, KML Leunissen, EKM Beukers, PJ Kingma, PM vd
Berg—Loonen, C vd Linden, PJG .Jorning, G Kootstra, RUL,
Maastricht, The Netherlands. We have experience with a new variant
of pancreas grafting in three patients with type I diabetes mellitus and
renal insufficiency. All patients are off dialysis and insulin, respectively
12, 9, and one month after transplantation. The patients received a
composite graft (whole pancreas, duodenum and spleen) and a kidney.
The composite graft and kidney have been transplanted in the right and
left fossa iliaca, respectively. A high percentage of pancreas transplan-
tations are complicated by thrombosis. By including the spleen a high
flow will be created which might circumvent this complication. Drain-
age of the exocrine secretion has been established via a duodeno-
cystotomy which offers the benefit of monitoring exocrine pancreas
function. In patient I and II the composite graft was transplanted
simultaneously with the kidney. In patient III the composite graft was
transplanted two months after a successful kidney graft. Immunosup-
pression consisted of cyclosporine A and 10 mg prednisolone. There
were no technical complications. The pancreas grafts functioned di-
rectly after transplantation. Since the transplantation, blood sugar
levels are in a normal range, The drainage of the exocrine secretion into
the bladder was well tolerated. The bladders are macroscopically and
microscopically normal. There is a bicarbonate loss of 10 grams per
day. In all three patients a rejection crisis has occurred, confirmed by a
renal biopsy. In all instances the rejection of the kidney was preceded
by a decrease of the production of the exocrine pancreas, which
suggests that there has been a rejection of the pancreas as well.
Notwithstanding the presence of a rejection of the pancreas blood sugar
levels remained in the normal range.
